# OSTEONIC

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/osteonic

- Industry: Medical Devices & Equipment
- Headquarters: Seoul, South Korea
- Website: www.osteonic.com/
- Total disclosed funding: $0.3M
- Latest round: Seed (Mar 1, 2013)
- Investors on record: 1

## About

OSTEONIC, based in Seoul, South Korea, specializes in the production of advanced bone and reconstructive implants, providing innovative medical solutions to healthcare providers and surgical centers globally.OSTEONIC, founded in 2012, focuses on the design and manufacturing of orthopedic medical devices. The company has successfully completed 10 deals since its inception, with its latest funding round occurring on February 22, 2018, where it raised KRW 9.24 billion through an IPO, selling 1.2 million shares. The firm is not known to have any subsidiaries or parent companies, nor has it undergone any significant strategic pivots. The founder's history is not documented in the available data.OSTEONIC specializes in the manufacturing of bone and reconstructive implants, offering a range of products primarily focused on metal and biodegradable composite-based solutions. Their core product offerings include the CMF (Optimus and Biobsorb) Plating Systems for fracture stabilization and reconstruction, the Trauma (Quantum) Plating System, and the Sports Medicine (Kinex) product line. Additionally, the Neuro Plating System and a newly launched Spine Products Line expand their capabilities to address complex surgical needs. OSTEONIC serves healthcare providers and surgical centers across various markets, including South Korea, Vietnam, Brazil, and the United States, with their products primarily utilized by orthopedic surgeons and medical professionals in trauma care and reconstructive surgery.OSTEONIC generates revenue through direct sales of its medical devices, including flagship products, to healthcare providers and institutions. Transactions occur through supply agreements with established partners in the medical industry, such as B.Braun and Zimmer Biomet, enhancing distribution channels. The company's B2B model supplies specialized products to hospitals and surgical centers, ensuring high-quality medical solutions for bone-related issues. Ongoing partnerships and collaborations, which may include exclusive distribution agreements, contribute to a steady revenue stream from their diverse product lines.OSTEONIC aims to enhance its product offerings by designing and launching new medical devices, although specific release dates are not mentioned. The company plans to expand into new markets, specifically targeting regions outside of its current presence, to increase its global footprint. The recent funding of KRW 9.24 billion will support these initiatives and facilitate the development and introduction of new products to meet the needs of an evolving healthcare landscape.

## Funding rounds

- Seed, Mar 1, 2013, $0.3M — Magellan Technology Investment

## Investors

- Magellan Technology Investment (https://capitalatlas.ai/funds/magellan-technology-investment) — Seed